3/14
07:52 am
capr
Earnings Beat: Capricor Therapeutics, Inc. (NASDAQ:CAPR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts [Yahoo! Finance]
Medium
Report
Earnings Beat: Capricor Therapeutics, Inc. (NASDAQ:CAPR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts [Yahoo! Finance]
3/13
11:38 am
capr
Has GSK PLC Sponsored ADR (GSK) Outpaced Other Medical Stocks This Year? [Yahoo! Finance]
Low
Report
Has GSK PLC Sponsored ADR (GSK) Outpaced Other Medical Stocks This Year? [Yahoo! Finance]
3/7
11:50 am
capr
Can Capricor (CAPR) Climb 261.27% to Reach the Level Wall Street Analysts Expect? [Yahoo! Finance]
Medium
Report
Can Capricor (CAPR) Climb 261.27% to Reach the Level Wall Street Analysts Expect? [Yahoo! Finance]
3/6
08:51 am
capr
Capricor Therapeutics Presents at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference [Yahoo! Finance]
Medium
Report
Capricor Therapeutics Presents at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference [Yahoo! Finance]
3/6
08:30 am
capr
Capricor Therapeutics Presents at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Medium
Report
Capricor Therapeutics Presents at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
3/3
08:04 am
capr
Capricor Therapeutics Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
Capricor Therapeutics Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
3/2
08:33 am
capr
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/1
08:14 am
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Low
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
2/29
04:58 pm
capr
Capricor Therapeutics Inc (CAPR) Reports Encouraging Year-End Financials and Advances in DMD Therapy [Yahoo! Finance]
Medium
Report
Capricor Therapeutics Inc (CAPR) Reports Encouraging Year-End Financials and Advances in DMD Therapy [Yahoo! Finance]
2/29
04:26 pm
capr
Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
2/29
04:05 pm
capr
Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Medium
Report
Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
2/27
01:03 pm
capr
Capricor Therapeutics Shares Rise 8% After FDA Meeting Set [MarketWatch]
Low
Report
Capricor Therapeutics Shares Rise 8% After FDA Meeting Set [MarketWatch]
2/27
08:43 am
capr
Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy [Yahoo! Finance]
Medium
Report
Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy [Yahoo! Finance]
2/27
08:30 am
capr
Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy
Medium
Report
Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy
2/22
08:33 am
capr
Capricor Therapeutics to Present Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Update on February 29 [Yahoo! Finance]
Low
Report
Capricor Therapeutics to Present Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Update on February 29 [Yahoo! Finance]
2/22
08:30 am
capr
Capricor Therapeutics to Present Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Update on February 29
Low
Report
Capricor Therapeutics to Present Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Update on February 29
2/20
01:20 pm
capr
Capricor scales up manufacturing capacity for DMD therapy [Seeking Alpha]
Low
Report
Capricor scales up manufacturing capacity for DMD therapy [Seeking Alpha]
2/20
08:38 am
capr
Capricor Therapeutics Announces Manufacturing Scale-Up of CAP-1002 Production at New San Diego Facility as it Continues Plans Toward Commercialization [Yahoo! Finance]
Low
Report
Capricor Therapeutics Announces Manufacturing Scale-Up of CAP-1002 Production at New San Diego Facility as it Continues Plans Toward Commercialization [Yahoo! Finance]
2/20
08:30 am
capr
Capricor Therapeutics Announces Manufacturing Scale-Up of CAP-1002 Production at New San Diego Facility as it Continues Plans Toward Commercialization
Medium
Report
Capricor Therapeutics Announces Manufacturing Scale-Up of CAP-1002 Production at New San Diego Facility as it Continues Plans Toward Commercialization
2/4
08:47 am
capr
Market Sentiment Around Loss-Making Capricor Therapeutics, Inc. (NASDAQ:CAPR) [Yahoo! Finance]
Medium
Report
Market Sentiment Around Loss-Making Capricor Therapeutics, Inc. (NASDAQ:CAPR) [Yahoo! Finance]
1/24
10:06 pm
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
1/24
10:35 am
capr
Capricor Therapeutics Shares Rise 7% After Collaboration for Covid-19 Vaccine [MarketWatch]
Medium
Report
Capricor Therapeutics Shares Rise 7% After Collaboration for Covid-19 Vaccine [MarketWatch]
1/24
09:37 am
capr
Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2 [Yahoo! Finance]
Medium
Report
Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2 [Yahoo! Finance]
1/24
09:15 am
capr
Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2
Medium
Report
Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2
1/5
08:09 am
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $8.00 price target on the stock.
Low
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $8.00 price target on the stock.